These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29889789)

  • 1. Does a "Fundal Fluid Cap" Predict Successful Hearing Preservation in Vestibular Schwannoma Resections Via the Middle Cranial Fossa Approach?
    Sun DQ; Kung RW; Hansen MR; Gantz BJ
    Otol Neurotol; 2018 Jul; 39(6):772-777. PubMed ID: 29889789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Hearing Preservation in Middle Cranial Fossa Resection of Vestibular Schwannoma.
    La Monte OA; Tawfik KO; Khan U; Schwartz M; Friedman R
    Otol Neurotol; 2022 Mar; 43(3):395-399. PubMed ID: 34999621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hearing preservation after middle fossa vestibular schwannoma removal: are the results durable?
    Quist TS; Givens DJ; Gurgel RK; Chamoun R; Shelton C
    Otolaryngol Head Neck Surg; 2015 Apr; 152(4):706-11. PubMed ID: 25628370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fundal fluid as a predictor of hearing preservation in the middle cranial fossa approach for vestibular schwannoma.
    Goddard JC; Schwartz MS; Friedman RA
    Otol Neurotol; 2010 Sep; 31(7):1128-34. PubMed ID: 20657334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of a "Fundal Fluid Cap" and Vestibular Schwannoma Volume: Analysis of Preoperative Radiographic Findings and Outcomes.
    Sullivan CB; Sun DQ; Al-Qurayshi Z; Bathla G; Policeni B; Gantz BJ; Hansen MR
    Otol Neurotol; 2019 Jan; 40(1):108-113. PubMed ID: 30239432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Hearing Outcomes in Conservatively Managed Vestibular Schwannoma Patients Utilizing Magnetic Resonance Imaging.
    Selleck AM; Rodriguez JD; Brown KD
    Otol Neurotol; 2021 Feb; 42(2):306-311. PubMed ID: 33290358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of a fundal fluid cap on preoperative magnetic resonance imaging may predict long-term facial nerve function after resection of vestibular schwannoma via the retrosigmoid approach.
    Fujita Y; Uozumi Y; Sasayama T; Kohmura E
    J Neurosurg; 2023 Apr; 138(4):972-980. PubMed ID: 36152320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscope-assisted middle fossa craniotomy for resection of inferior vestibular nerve schwannoma extending lateral to transverse crest.
    Master AN; Roberts DS; Wilkinson EP; Slattery WH; Lekovic GP
    Neurosurg Focus; 2018 Mar; 44(3):E7. PubMed ID: 29490550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fundal Fluid Cap Is Associated With Hearing Preservation in the Radiosurgical Treatment of Vestibular Schwannoma.
    Bojrab DI; Fritz CG; Lin KF; Schutt CA; Hong RS; Babu SC; Chen PY; Maitz A; Bojrab DI
    Otol Neurotol; 2021 Jan; 42(1):137-144. PubMed ID: 33055496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Middle Fossa Approach for Vestibular Schwannoma: Good Hearing and Facial Nerve Outcomes with Low Morbidity.
    Raheja A; Bowers CA; MacDonald JD; Shelton C; Gurgel RK; Brimley C; Couldwell WT
    World Neurosurg; 2016 Aug; 92():37-46. PubMed ID: 27150655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Well Does Intraoperative Audiologic Monitoring Predict Hearing Outcome During Middle Fossa Vestibular Schwannoma Resection?
    Sun DQ; Sullivan CB; Kung RW; Asklof M; Hansen MR; Gantz BJ
    Otol Neurotol; 2018 Aug; 39(7):908-915. PubMed ID: 29912825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hearing preservation in acoustic neuroma surgery: middle fossa versus retrosigmoid approach.
    Staecker H; Nadol JB; Ojeman R; Ronner S; McKenna MJ
    Am J Otol; 2000 May; 21(3):399-404. PubMed ID: 10821555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas.
    Carlson ML; Vivas EX; McCracken DJ; Sweeney AD; Neff BA; Shepard NT; Olson JJ
    Neurosurgery; 2018 Feb; 82(2):E35-E39. PubMed ID: 29309683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Radiographic Predictors of Hearing Preservation After Retrosigmoid Resection of Vestibular Schwannomas.
    Ren Y; Tawfik KO; Mastrodimos BJ; Cueva RA
    Otolaryngol Head Neck Surg; 2021 Aug; 165(2):344-353. PubMed ID: 33290167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hearing preservation and facial nerve outcomes in vestibular schwannoma surgery: results using the middle cranial fossa approach.
    Arts HA; Telian SA; El-Kashlan H; Thompson BG
    Otol Neurotol; 2006 Feb; 27(2):234-41. PubMed ID: 16436995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small acoustic neuromas: surgical outcomes versus observation or radiation.
    Meyer TA; Canty PA; Wilkinson EP; Hansen MR; Rubinstein JT; Gantz BJ
    Otol Neurotol; 2006 Apr; 27(3):380-92. PubMed ID: 16639278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Middle Fossa Approach for Resection of Vestibular Schwannomas: A Decade of Experience.
    Kosty JA; Stevens SM; Gozal YM; DiNapoli VA; Patel SK; Golub JS; Andaluz NO; Pensak M; Zuccarello M; Samy RN
    Oper Neurosurg (Hagerstown); 2019 Feb; 16(2):147-158. PubMed ID: 29889286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve of origin, tumor size, hearing preservation, and facial nerve outcomes in 359 vestibular schwannoma resections at a tertiary care academic center.
    Jacob A; Robinson LL; Bortman JS; Yu L; Dodson EE; Welling DB
    Laryngoscope; 2007 Dec; 117(12):2087-92. PubMed ID: 17921903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of nerve branch of origin and extracanalicular extension of the tumor on hearing after middle fossa removal of vestibular schwannoma.
    Fiscina F; Gouveris H; Mann W
    Acta Otolaryngol; 2007 Oct; 127(10):1058-61. PubMed ID: 17851965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hearing preservation with the middle cranial fossa approach for neurofibromatosis type 2.
    Friedman RA; Goddard JC; Wilkinson EP; Schwartz MS; Slattery WH; Fayad JN; Brackmann DE
    Otol Neurotol; 2011 Dec; 32(9):1530-7. PubMed ID: 21986931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.